TITLE:
Hyperuricaemia in Type 2 Diabetic Patients at the Marc Sankalé Centre of Abass Ndao Hospital (Dakar): Prevalence and Associated Factors
AUTHORS:
Djiby Sow, Michel Assane Ndour, Mouhamed Dieng, Ibrahima Mané Diallo, Ndiouga Fall, Ndeye Fatou Fall, Boundia Djiba, Fatou Kiné Gadji, Matar Ndiaye, Boun Khatab Diouf, Demba Diedhiou, Anna Sarr, Mbaye Maimouna Ndour
KEYWORDS:
Hyperuricaemia, Type 2 Diabetes, Cardiovascular Risk Factors, Senegal
JOURNAL NAME:
Open Journal of Endocrine and Metabolic Diseases,
Vol.16 No.3,
March
17,
2026
ABSTRACT: Introduction: Hyperuricaemia is frequently associated with type 2 diabetes and contributes to increased morbidity and mortality, particularly cardiovascular and renal. The aim of this study was to investigate the prevalence of hyperuricaemia and associated factors in patients with type 2 diabetes monitored at the Abass Ndao Hospital Centre in Dakar. Materials and Methods: This was a retrospective descriptive and analytical study conducted over a one-year period, from 1 January to 31 December 2022. Data were collected from the medical records of type 2 diabetic patients who had undergone uric acid testing. Statistical analysis was performed using Epi Info 2000 software version 3.3.2. Results: Hyperuricaemia was found in 66 patients, representing a prevalence of 16.7%, with a male/female ratio of 0.5. The average age was 60.6 ± 9.7 years. The average duration of diabetes was 10.5 ± 8.4 years. Hypertension was associated in 57.6% of hyperuricaemic cases compared with 41.6% in non-hyperuricaemic cases (p = 0.017). Renal impairment (22.7%) and anaemia (29.5%) were significantly more common in hyperuricaemic patients. Gout was found in 6% of patients. Conclusion: Hyperuricaemia is relatively common in patients with type 2 diabetes and is associated with several cardiometabolic and renal risk factors. Systematic screening and integrated management could help reduce morbidity and mortality in diabetic patients.